Objective
to report the 10-year clinical outcomes of everolimus-eluting stents (EES) compared to bare metal stents (BMS) for the treatment of STEMI patients
Study
prospective multicentre single blind randomised trial
Population
all-comers with STEMI
Endpoints
composite of all-cause death, any MI or any revascularisation at 10 years
Conclusion
EES implantation was associated with a continued 10-year better clinical outcome compared to BMS implantation for treatment of STEMI patients
Brugaletta et al. J Am Coll Cardiol. 2021;77:1165-78
